4.2 Review

Recent progress of oridonin and its derivatives for cancer therapy and drug resistance

Journal

MEDICINAL CHEMISTRY RESEARCH
Volume 30, Issue 10, Pages 1795-1821

Publisher

SPRINGER BIRKHAUSER
DOI: 10.1007/s00044-021-02779-6

Keywords

Natural products; Oridonin; Structural modification; Anticancer activity; Drug resistance

Funding

  1. National Natural Sciences Foundations of China [81703541, U2004123, 81673322]
  2. China Postdoctoral Science Foundation [2018M632812]
  3. Henan Association of Science and Technology [2020HYTP056]
  4. Science and Technology Department of Henan Province [20202310144]
  5. state key laboratory of Pharmaceutical Biotechnology, Nan-jing University, China [KF-GN-202101]

Ask authors/readers for more resources

Oridonin, derived from traditional Chinese medicine Isodon rubescens, shows various biological functions such as anticancer, anti-inflammation, and antibacterial properties. Despite multiple anticancer mechanisms, its poor pharmaceutical properties have hindered its clinical research and application. Researchers are working to improve oridonin's pharmaceutical properties for potential anticancer use.
Numerous antitumor drugs exhibited excellent anti-proliferation activities, discovered from natural products. Oridonin is isolated from a traditional Chinese medicine Isodon rubescens, and it exhibit various biological functions including anticancer, anti-inflammation, antibacterial, and so on. The anticancer mechanisms of oridonin include apoptosis, autophagy, cell cycle arrest, and so on. However, clinical research and application of oridonin has been hampered, due to the poor pharmaceutical property. So many studies on oridonin have been explored in the purpose of improve the pharmaceutical property, including investigation of the mechanism of action in depth and structural modification. In this review, we summarized oridonin and oridonin derivatives as potential anticancer agents, and detailed discussion on biological properties, mechanism of actions and potential for overcoming therapeutic resistance.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available